Table 2.
Multivariate analysis of clinical parameters influencing risk of cardiac adverse events
OR | 95% CI | P-value | |
---|---|---|---|
Prior history of cardiac events | |||
No | 1 | − | .045 |
Yes | 3.48 | 1.03–12.8 | |
Use of antithrombotic agents | |||
No | 1 | − | .056 |
Yes | 3.66 | 0.97–8.79 | |
Duration of PI therapy | 1.94 | 1.21–3.09 | .006 |
Abbreviations: OR odds ratio, CI confidence interval, PI proteasome inhibitor